top of page

CORRECTION - LALPINA Water Founder Alfred Culbreth Launches LALPINA IV, an Intravenous Micronutrient

CORRECTION - LALPINA Water Founder Alfred Culbreth Launches LALPINA IV, an Intravenous Micronutrient Therapy Product Line, and Website LalpinaIV.com


MIAMI, FL--(Marketwired - Apr 4, 2016) - In the news release, "LALPINA Water Founder Alfred Culbreth Launches LALPINA IV, an Intravenous Micronutrient Therapy Product Line, and Website LalpinaIV.com," issued Thursday, March 31 by American Premium Water Corporation (OTCBB: HIPH), we are informed by the company that there have been changes and this version corrects and replaces any prior versions. Complete corrected text follows.

LALPINA Water Founder Alfred Culbreth Launches LALPINA IV, an Intravenous Micronutrient Therapy Product Line, and Website LalpinaIV.com

This Will Broaden Market Position Into "Natural" Biotech Space

MIAMI, FL -- Mar 31, 2016 -- American Premium Water Corporation (OTCBB: HIPH). Naturalist Alfred Culbreth, founder and CEO of LALPINA Water (OTCBB: HIPH), today announced the launch of LALPINA IV, the company's branded intravenous micronutrient therapy treatment, and an accompanying website, www.LalpinaIV.com.

Also known as a Myers cocktail, intravenous micronutrient therapy is the practice of treating fatigue or certain other health conditions with a customized blend of vitamins and nutrients injected directly into to the body. Culbreth, a lean, fit 52 year-old, smiles at the suggestion he's at the center of one of the hottest trends in the natural health sector.

"IVs have been a part of my own health regimen for years now," he said. "I don't sell anything I'm not already into myself, but it's true the interest from our practitioner base is growing very quickly." Used for decades, intravenous micronutrient therapy has been used to deliver essential vitamin, minerals, amino acids, and various compounds directly to the human body for therapeutic use. The Company creatively partners with naturopaths or health spas wishing to carry LALPINA IV or water, utilizing stock and cash consideration in the agreement. Its IV product line is the first initiative in broadening its market position beyond the realm of strictly high pH water and into the "natural" biotech space.

"LALPINA is about optimum health," enthused Culbreth, "and just as health requires several key elements working together, our product line will be the same." Twitter: @americanpremium / @lalpinawater Instagram #lalpinawater

Safe Harbor Notice Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

This press release is issued on behalf of the Board of Directors by Alfred Culbreth, CEO and Director.

Disclaimer Regarding Forward Looking Statements Certain statements in this press release, on American Premium Water Corporation's ("APWC") website and other oral and written statements made by APWC from time to time are "forward-looking statements", as that term is defined in Section 27A of the United States Securities and Exchange Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended, Forward-looking statements include, without limitation, statements regarding beliefs, objectives, intentions, goals, plans, strategies, financial projections, any other statements regarding the future and any statements that are not purely historical. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and APWC expressly disclaims any obligation to update or revise any forward-looking statements to reflect events or circumstances after the date thereof. All forward-looking statements, whether written or oral and whether made by or on behalf of the APWC, are expressly qualified by these cautionary statements. Forward-looking statements involve risks and uncertainties which could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. APWC's expectations, beliefs and projections are expressed in good faith and are believed by the APWC to have a reasonable basis, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. A variety of factors, many of which are beyond APWC's control affect APWC's operations, performance, business strategy and results and could cause the actual results, performance or achievements of APWC to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. For APWC, particular uncertainties arise, amongst others but not limited to and not in any order of importance, from (i) focusing on and allocating more resources on certain target markets (ii) the possibility to raise further equity and debt to fund future growth, (iii) changes in demand for APWC's products, (iv) performance issues with key suppliers, affiliates, agents, advisors or subcontractors, (v) changes in government changes in laws or regulations to which APWC or its suppliers are subject, including environmental laws and regulations relating to water or water sources and (vi) the inability to complete announced acquisitions, difficulty or unanticipated expenses in connection with integrating acquired businesses and the risk that anticipated synergies and opportunities as a result of acquisitions will not be realized or the risk that acquisitions do not perform as planned, including, for example, the risk that acquired businesses will not achieve revenue projections.

THIS NEWS RELEASE HAS BEEN PREPARED BY APWC'S MANAGEMENT, WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS. NO SECURITIES REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THE CONTENTS OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.


Contact Information: American Premium Water Corporation 12777 Jefferson Blvd., Building 'D', Third Floor Playa Vista, CA 90066-7408 (888)-983-0054 Stock Symbol: HIPH General Inquiries: info@americanpremiumwater.com Investor Relations: ir@americanpremiumwater.com Company Website: www.americanpremiumwater.com

Recent Posts

See All
bottom of page